Solution

Analytics & Data Platforms for Pharmaceutical

Build analytics capabilities that accelerate clinical decisions, optimize commercial performance, and generate the evidence regulators and payers demand.

Pharmaceutical companies need analytics that span clinical development, commercial operations, medical affairs, and market access. Adapter builds analytics platforms that unify data across these functions and deliver insights that accelerate timelines and improve outcomes.

Key Challenges

  • Multi-Source Data Integration Complexity
  • Regulated Data Environments
  • Real-World Evidence Generation

Overview

Analytics & Data Platforms for Pharmaceutical

Pharmaceutical analytics must serve some of the most data-intensive and highly regulated use cases in any industry. Clinical teams need real-time enrollment tracking, safety signal monitoring, and endpoint analysis. Commercial teams need territory performance dashboards, HCP engagement analytics, and launch tracking. Medical affairs needs publication tracking, KOL mapping, and real-world evidence generation. Market access teams need payer analytics, formulary tracking, and health economics data. Each of these functions has specific data sources, analysis requirements, and regulatory constraints.

Adapter builds analytics platforms that unify these disparate data needs. We start by designing data architectures that connect clinical trial management systems, electronic data capture platforms, CRM and marketing automation tools, claims and prescription databases, and real-world data sources into a governed data ecosystem. Our architectures follow FAIR principles (Findable, Accessible, Interoperable, Reusable) and implement the access controls and audit trails required for GxP-adjacent and commercially sensitive data.

From this foundation, we build analytics solutions for each functional area. Clinical analytics include enrollment dashboards, site performance scorecards, safety signal detection, and data quality monitoring. Commercial analytics include prescriber-level Rx trends, sales force effectiveness metrics, market share tracking, and promotional response models. RWE (Real-World Evidence) analytics include treatment pattern analysis, comparative effectiveness studies, and patient outcome tracking using claims, EHR, and registry data. Every analytics solution includes self-service capabilities that allow domain experts to explore data independently while maintaining the governance and compliance standards that pharmaceutical environments require.

What we deliver

Solutions

  • 01

    Pharma Data Lakehouse Architecture

  • 02

    21 CFR Part 11 Compliant Analytics

  • 03

    RWE Analytics Platform

  • 04

    Federated Data Governance Model

Industry Challenges

Problems we solve

01

Multi-Source Data Integration Complexity

Pharma analytics requires combining clinical trial data, claims databases, EHR records, commercial data feeds, and manufacturing data, each with different formats and governance requirements.

02

Regulated Data Environments

Analytics systems that touch clinical data must comply with 21 CFR Part 11, HIPAA, and international data protection regulations, adding validation and access control requirements.

03

Real-World Evidence Generation

Payers and regulators increasingly demand real-world evidence alongside clinical trial data, requiring analytics platforms that can analyze diverse, real-world data sources at scale.

04

Cross-Functional Data Governance

Clinical, commercial, and medical affairs teams all generate and consume data, but governance policies, access rights, and quality standards often conflict or overlap.

What We Build

Our approach

Pharma Data Lakehouse Architecture

We design unified data platforms that combine the flexibility of data lakes with the governance of data warehouses, supporting both regulated clinical analytics and exploratory commercial analysis.

21 CFR Part 11 Compliant Analytics

Our analytics platforms implement electronic signatures, audit trails, access controls, and validation documentation required for clinical and GxP-adjacent analytical environments.

RWE Analytics Platform

We build platforms that ingest and analyze claims, EHR, registry, and patient-reported outcome data to generate the real-world evidence that payers and regulators increasingly require.

Federated Data Governance Model

We establish governance frameworks that respect functional data ownership while enabling cross-functional analytics through standardized data contracts and access policies.

Results

What you can expect

50% faster clinical data availability for analysis

Automated data pipelines and standardized formats reduce the time between data collection and analytical availability for clinical decision making.

Real-world evidence supporting 2 payer negotiations

RWE analytics platforms generate the comparative effectiveness and outcomes evidence that strengthen formulary access negotiations with major payers.

30% reduction in commercial reporting cycle time

Automated data pipelines and pre-built commercial analytics eliminate the manual data compilation that delays weekly and monthly performance reviews.

FAQ

Common questions

Things clients typically ask about analytics in this industry.

Ready to get started?

Tell us about your project and we will scope an engagement that fits.